Top Analytics Companies in NYC, NY (508)

Strong Revenue Growth: FY2026 results show company sales increased to roughly $8.0B, with underlying (comparable) growth strengthening after excluding the divested business. Brand-level detail indicates Coach delivered robust double-digit gains that powered the consolidated uptrend.

Profitability: Adjusted operating income and earnings per share rose markedly for FY2026 alongside operating-margin expansion. Management’s FY2027 outlook also calls for further margin improvement with low double-digit EPS growth.

Market Expansion: Growth was broad-based geographically, with notable increases in Europe and Greater China and continued strength in direct-to-consumer channels. The customer base expanded by millions in FY2026, including a meaningful Gen Z cohort.

Market Expansion: Customer reach is described as 500+ brands and 150+ agency and media partners in 2026, indicating a broad commercial footprint. Added distribution via a Comcast Advertising partnership further extends access to advertisers.

Innovation-Driven Growth: The launch of AI Search Lift in 2026 signals investment in emerging ad-measurement categories like LLM and AI-driven discovery. Product activity and new measurement offerings point to continued platform development.

Strategic Partnerships: New alliances, such as the Comcast Advertising integration for advanced TV attribution, are highlighted as expanding distribution and market access. Selection by major media companies like Warner Bros. Discovery reinforces enterprise credibility.

Strong Hiring & Retention: Headcount and hiring momentum are evident, with third-party estimates showing growth from roughly the mid‑teens of thousands in 2024 to 20,000+ by 2025–2026 and plans to hire thousands, alongside new capacity such as the Hyderabad operations center. This suggests the company is scaling delivery and talent depth across geographies.

Innovation-Driven Growth: The firm has expanded into AI and digital offerings, including its ZAIDYN platform, acquisitions like Digital Additive and Torrent Consulting, and launches such as Myelo developed with the International Myeloma Foundation. These moves indicate investment beyond traditional consulting into scalable, tech‑enabled services.

Market Expansion: A dedicated mid‑cap pharmaceutical vertical and the opening of an operations center in Hyderabad point to deliberate expansion in target segments and delivery footprint. These steps signal efforts to broaden served markets and strengthen execution capacity.

Strong Revenue Growth: Reported annual recurring subscription and service revenue grew by more than 220% in 2025, resulting in ARR more than tripling. The increase is attributed to new and expanding relationships with private‑equity sponsors and their portfolio companies.

Market Expansion: Sponsor partnerships are described as having doubled, broadening commercial reach across private‑equity networks. The company also scaled geographically, adding offices in locations such as Chicago, New York, Toronto, Dallas, and Bengaluru.

Product Line Growth: New offerings include the Astradis platform, an AI‑powered pricing suite, expanded healthcare functionality, and the launch of Astra Labs. These additions broaden the addressable market and signal continued investment in AI‑driven solutions.

Strong Revenue Growth: Feedback suggests ARR surpassed $500M in 2023 and was described as approaching $600M in 2024, indicating meaningful scaling of recurring revenue. Company statements also highlight strong growth in power and renewables since 2021.

Market Expansion: Feedback suggests multiple acquisitions (e.g., Spatial Business Systems, PDS exchange assets, A2D well log library) and launches (Enverus ONE, Minerals Marketplace) broaden capabilities into utilities, operational data, and AI-driven workflows. These moves extend reach beyond traditional oil and gas into power and renewables.

Investor Backing & Capital Strength: Feedback suggests Blackstone agreed to acquire the company in 2025 at a multibillion-dollar valuation, signaling institutional confidence and potential resources for further growth. Prior backing by Hellman & Friedman and Genstar also indicates sustained capital support.

Strong Market Position & Advantage: Celonis is repeatedly characterized as the dominant pioneer and market leader in process mining and process intelligence, with sustained recognition from Gartner, Forrester, and Everest and visibility in rankings like the Fortune Future 50 and Forbes Cloud 100. This position is reinforced by a substantial enterprise footprint, including thousands of deployments across more than 20 global locations.

Innovation-Driven Growth: The company is extending beyond traditional dashboards into operational AI, launching its Context Model, adding AI copilots, and agreeing to acquire Ikigai Labs to bolster decision intelligence. These moves signal an evolution toward automated execution and higher platform stickiness among large enterprises.

Strategic Partnerships: Integrations and collaborations with Microsoft, Oracle, AWS, and Databricks embed Celonis within major enterprise data and AI ecosystems. This ecosystem presence expands distribution paths and strengthens its role as an operational context layer for enterprise AI.

Strong Market Position & Advantage: PSA’s grading activity scaled to well over 19 million cards in 2025 and continued rising into 2026, while the portfolio also includes SGC and an agreement to add Beckett. This combination points to a commanding position in trading-card authentication and grading.

Market Expansion: New and expanded facilities in the U.S. and internationally, coupled with portfolio additions like the planned Beckett acquisition, extend geographic and category reach. Headcount has grown into the thousands with ongoing recruiting across functions.

Investor Backing & Capital Strength: A $200 million program was announced to expand PSA’s footprint, technology, and staffing over 18 months, alongside prior financing that valued the company in the billions. These commitments indicate ample capital available to scale capacity in response to rising demand.

Strong Revenue Growth: Company disclosures point to multi‑year top‑line expansion, with independent credit commentary anticipating continued gains. The scale of the installed healthcare network reinforces commercial traction over time.

Market Expansion: Recent launches of a Consumer Health Network and programmatic advertising capabilities extend reach beyond traditional pharmaceutical clients and open new buying channels. These moves indicate active growth into adjacent advertiser categories within healthcare settings.

Investor Backing & Capital Strength: A definitive agreement to be acquired by a global private‑equity firm underscores institutional confidence and adds resources to accelerate network growth and product innovation. The transaction highlights access to capital to support scaling.

Strong Revenue Growth: Revenue surpassed $1 billion in Q3 2026 for the first time, and annual revenue rose from about $2.1 billion in 2023 to $3.15 billion in 2025, with the first nine months of 2026 continuing to climb. This trajectory reflects momentum across multiple periods rather than a single-quarter spike.

Profitability: Net income and adjusted EPS increased faster than revenue in recent periods, and the net revenue margin improved year over year. These patterns point to expanding earnings alongside top-line growth.

Diversified Revenue Streams: Growth is broad-based across small-business and consumer lending, with both originations, receivables, and segment revenues rising in Q3 2026. The small-business portfolio represents a meaningful share of receivables and continues to scale.

Strong Revenue Growth: Recent financial results highlight sustained top-line expansion with rising quarterly revenue and management increasing full‑year guidance, indicating momentum across 2025 and into 2026.

Diversified Revenue Streams: Growth is coming from both diagnostics and data licensing/AI applications, with testing volumes and data contracts expanding rather than reliance on a single line of business.

Customer Loyalty & Retention: Reported net revenue retention above 100% and sizable remaining contract value suggest existing pharmaceutical customers are deepening engagements.

Strong Revenue Growth: Revenue reportedly grew nearly sevenfold in 2025, indicating rapid commercial acceleration. Subsequent disclosures also describe expanding deployments across the U.S., Europe, and the Middle East.

Investor Backing & Capital Strength: A $22 million Series A announced on January 29, 2026 provided capital to scale the forward-deployed engineering model and AI application platform. An agreed acquisition by The OpenAI Deployment Company further signals strong strategic interest.

Strategic Partnerships: Designation as Palantir’s first and only Vanguard: Elite partner underscores a privileged ecosystem position tied to customer deployment success. The launch of a Google Cloud Gemini Enterprise practice points to broadening alliance activity.

Investor Backing & Capital Strength: Investor support is substantial, highlighted by a $65 million Series C led by Goldman Sachs Alternatives and a subsequent $35 million debt facility, providing significant resources for scaling. These financings, together exceeding $100 million in 2026, indicate strong confidence in continued expansion.

Product Line Growth: The offering is broadening with launches such as Sage Detect, Tasking, and Labor, alongside expanded EHR integrations and an entry into skilled nursing. This trajectory moves the company beyond safety monitoring into integrated workflows and workforce/operational management.

Market Expansion: The platform is described as live in hundreds of senior-care communities across 26 states, with portfolio-level rollouts like Navion’s phased deployment across 47 communities. Hiring in sales, account management, deployment, and engineering further supports ongoing commercial expansion.

Strong Hiring & Retention: Employee headcount is increasing over the 2023–2026 period, indicating ongoing hiring momentum. Feedback suggests workforce expansion is sustained even if the pace has moderated recently.

Market Expansion: A new Jakarta office was opened in 2026 to deepen engagement across Southeast Asia. Operations span dozens of offices in many countries, supporting customers in more than 80 countries.

Innovation-Driven Growth: New offerings such as the Data Studio AI Assistant and continued development of healthcare interoperability products point to active product investment. Feedback suggests AI and healthcare enhancements are a current strategic focus.

Strong Revenue Growth: Revenue is expanding rapidly, with 30% full-year growth in 2025 and 44% year over year in Q2 2026, alongside raised 2026 revenue guidance of roughly 39–40%.

Healthy Cash Flow: Cash generation is strengthening, with free cash flow up 78% in 2025 and 73% in Q2 2026, and 2026 free-cash-flow guidance around $255 million.

Profitability: Profitability is improving, highlighted by positive GAAP net income in Q2 2026 and an adjusted EBITDA margin of about 20.7% with continued expansion.

Investor Backing & Capital Strength: Recent financing momentum is evident, with a $70M Series C in May 2025 led by Avra and participation from firms such as Andreessen Horowitz, Sequoia, Redpoint, and Snowflake Ventures. This capital is positioned to support further product and go-to-market expansion while signaling confidence in the company’s trajectory.

Market Expansion: Customer adoption appears to be broadening from more than 1,500 teams in May 2025 to more than 2,000 customers globally, including enterprises like Reddit, Figma, HubSpot, Rivian, and Anthropic. Evidence of scaling usage, such as hundreds of millions of usage-based billing events and increased adoption of advanced compute add-ons, reinforces this expansion.

Innovation-Driven Growth: Product momentum centers on AI-powered analytics and agentic workflows, including features like the Notebook Agent and moves into embedded analytics. The acquisition of Hashboard and introduction of usage-based monetization for advanced compute suggest continued innovation aligned with market shifts.